LYTIR

Insider · SEC Form 4 · CEO

Willis C. Lee

Filed with the SEC as LEE WILLIS C; the order above is the one the filer's own signature uses.

In the 12 months to Nov 8, 2026, on the open market: bought $15K of EMMA. Filed a median of 3 business days after the trade.

Open-market purchases and sales this filer reported on SEC Form 4, by the day traded. Insiders have two business days to file. A sale marked 10b5-1 was made under a plan adopted in advance. How to read these

  1. EMMABought: Emmaus Life Sciences, Inc. Aug 31, 2026 100,000 shares filed Sep 2, 2026 690,167 shares held indirectly after, as filed filing $5K
  2. EMMABought: Emmaus Life Sciences, Inc. Aug 28, 2026 94,767 shares filed Sep 2, 2026 590,167 shares held indirectly after, as filed filing $6K
  3. EMMABought: Emmaus Life Sciences, Inc. Aug 27, 2026 50,000 shares filed Sep 2, 2026 495,400 shares held indirectly after, as filed filing $2K
  4. EMMABought: Emmaus Life Sciences, Inc. Aug 25, 2026 46,000 shares filed Sep 2, 2026 445,400 shares held indirectly after, as filed filing $2K

Source: SEC Form 4 filings. Value is shares × the price reported on the filing; a filing whose price failed Lytir's check against the market price is left out, and a trade that related owners reported on separate forms is counted once. Filings can be late, amended or wrong at the source; see methodology.